Featured ConferencesAmerican Diabetes AssociationThe Endocrine SocietyAmerican Heart Association/American Stroke AssociationAmerican Academy of Pain MedicineAmerican Psychiatric AssociationAmerican College of RheumatologyAll CoverageCardiovascular DisordersNovel Oral Drug Takes Next Step in Race to Lower Lipoprotein(a)Patrice WendlingNews5 Min ReadMuvalaplin is the first oral drug among a host of injectable agents to target this common but underdiagnosed cardiovascular risk factor. AHA 2024 conference coverage. Cardiovascular DisordersNovel Oral Drug Takes Next Step in Race to Lower Lipoprotein(a)Patrice WendlingNews5 Min ReadMuvalaplin is the first oral drug among a host of injectable agents to target this common but underdiagnosed cardiovascular risk factor. AHA 2024 conference coverage. Cardiovascular DisordersBlood Thinners Fail to Prevent Cognitive Decline, Stroke in AFPatrice WendlingNews5 Min ReadThe BRAIN-AF results dash hopes for anticoagulation in younger, low-risk patients. AHA 2024 Conference Coverage. Cardiovascular DisordersBlood Thinners Fail to Prevent Cognitive Decline, Stroke in AFPatrice WendlingNews5 Min ReadThe BRAIN-AF results dash hopes for anticoagulation in younger, low-risk patients. AHA 2024 Conference Coverage. Arthritis & Rheumatic DiseasesNatural Killer Cell Therapy: An “Off-the-Shelf” Option for SLE?Kathleen DohenyNews3 Min ReadCould an allogenic approach replace CAR T cell therapy? ACR Convergence 2024 coverage. Arthritis & Rheumatic DiseasesNatural Killer Cell Therapy: An “Off-the-Shelf” Option for SLE?Kathleen DohenyNews3 Min ReadCould an allogenic approach replace CAR T cell therapy? ACR Convergence 2024 coverage. Rheumatoid ArthritisSteroids: When to Taper, When to PrescribeHeidi SpleteInterview4 Min ReadRheumatologist Beth Wallace, MD, MSc, provides tips for prescribers and addresses points still under debate. ACR Convergence 2024 coverage. Rheumatoid ArthritisSteroids: When to Taper, When to PrescribeHeidi SpleteInterview4 Min ReadRheumatologist Beth Wallace, MD, MSc, provides tips for prescribers and addresses points still under debate. ACR Convergence 2024 coverage. Cardiovascular DisordersTirzepatide Cuts Heart Failure Events in People with ObesityPatrice WendlingNews5 Min ReadSUMMIT trial widens pathway for GLP-1 agonists, experts say. AHA 2024 meeting coverage. Cardiovascular DisordersTirzepatide Cuts Heart Failure Events in People with ObesityPatrice WendlingNews5 Min ReadSUMMIT trial widens pathway for GLP-1 agonists, experts say. AHA 2024 meeting coverage. Obesity & Weight ManagementDrug Labeling Gaps for Patients with Obesity Could Lead to Poor OutcomesLeah LawrenceNews5 Min ReadWhat does the FDA intend to do? Plus, how to avoid prolonged drug-drug interactions. An ObesityWeek 2024 highlight. Obesity & Weight ManagementDrug Labeling Gaps for Patients with Obesity Could Lead to Poor OutcomesLeah LawrenceNews5 Min ReadWhat does the FDA intend to do? Plus, how to avoid prolonged drug-drug interactions. An ObesityWeek 2024 highlight. Arthritis & Rheumatic DiseasesVitamin D and Infection: It’s Not Just for Bone Health AnymoreKathleen DohenyInterview4 Min ReadMargherita Cantorna, PhD, shares her findings on Vitamin D for regulating the immune system, inflammation, gut function, and more. ACR Convergence 2024 coverage. Arthritis & Rheumatic DiseasesVitamin D and Infection: It’s Not Just for Bone Health AnymoreKathleen DohenyInterview4 Min ReadMargherita Cantorna, PhD, shares her findings on Vitamin D for regulating the immune system, inflammation, gut function, and more. ACR Convergence 2024 coverage. OsteoarthritisNovel Treatment for Knee Osteoarthritis EmergesKathleen DohenyNews4 Min ReadInfusion improves knee pain and function without ill effects on joints. ACR Convergence 2024 coverage. OsteoarthritisNovel Treatment for Knee Osteoarthritis EmergesKathleen DohenyNews4 Min ReadInfusion improves knee pain and function without ill effects on joints. ACR Convergence 2024 coverage. Asthma & AllergyCombination Inhalers Best for Severe AsthmaGreg SackuvichNews3 Min ReadNew ACAAI/AAAAI guideline expected to address inflammation and treatment protocols. Asthma & AllergyCombination Inhalers Best for Severe AsthmaGreg SackuvichNews3 Min ReadNew ACAAI/AAAAI guideline expected to address inflammation and treatment protocols. Gastrointestinal DisordersOn-Demand Vonoprazan Nearly as Effective as Daily Use for NERDLeah LawrenceNews4 Min ReadStudy results showed rapid and sustained relief for individuals with nonerosive reflux disease after a run-in period. An ACG highlight. Gastrointestinal DisordersOn-Demand Vonoprazan Nearly as Effective as Daily Use for NERDLeah LawrenceNews4 Min ReadStudy results showed rapid and sustained relief for individuals with nonerosive reflux disease after a run-in period. An ACG highlight. Gastrointestinal DisordersGLP-1 Receptor Agonists Linked to 53% Lower Rate of Pancreatic CancerLeah LawrenceNews3 Min ReadComparative study of people with type 2 diabetes offers another promising area for this drug class. An ACG highlight. Gastrointestinal DisordersGLP-1 Receptor Agonists Linked to 53% Lower Rate of Pancreatic CancerLeah LawrenceNews3 Min ReadComparative study of people with type 2 diabetes offers another promising area for this drug class. An ACG highlight. Kidney DiseaseCreatinine-Based GFR Estimations Fall Short in Heart FailureOladimeji EwumiNews5 Min ReadMayo Clinic study finds one eGFR equation provides a closer estimate of actual kidney function in this patient population. A Kidney Week 2024 highlight. Kidney DiseaseCreatinine-Based GFR Estimations Fall Short in Heart FailureOladimeji EwumiNews5 Min ReadMayo Clinic study finds one eGFR equation provides a closer estimate of actual kidney function in this patient population. A Kidney Week 2024 highlight.
